| Ident. | Authors (with country if any) | Title |
|---|
| 001477 (2018) |
Peter A. Nigrovic [États-Unis] ; Timothy Beukelman [États-Unis] ; George Tomlinson [Canada] ; Brian M. Feldman [Canada] ; Laura E. Schanberg [États-Unis] ; Yukiko Kimura [États-Unis] | Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST). |
| 001561 (2017) |
Mari Kihara [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Lianne Kearsley-Fleet [Royaume-Uni] ; Kath D. Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Deborah P M. Symmons [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] | Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis. |
| 001596 (2017) |
Laura C. Cappelli [États-Unis] ; Judy Lynn Palmer [États-Unis] ; Joel Kremer [États-Unis] ; Clifton O. Bingham [États-Unis] | Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis. |
| 001627 (2017) |
Timothy Beukelman [États-Unis] ; Yukiko Kimura [États-Unis] ; Norman T. Ilowite [États-Unis] ; Kelly Mieszkalski [États-Unis] ; Marc D. Natter [États-Unis] ; Grendel Burrell [États-Unis] ; Brian Best [États-Unis] ; Jason Jones [États-Unis] ; Laura E. Schanberg [États-Unis] | The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months. |
| 001653 (2017) |
Dong-Jin Park [Corée du Sud] ; Sung Jae Choi [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud] ; Yong-Beom Park [Corée du Sud] ; Seong Wook Kang [Corée du Sud] ; Seung-Ki Kwok [Corée du Sud] ; Seong-Kyu Kim [Corée du Sud] ; Eon Jeong Nam [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Jaejoon Lee [Corée du Sud] ; Chang Hoon Lee [Corée du Sud] ; Chan Hong Jeon [Corée du Sud] ; Shin-Seok Lee [Corée du Sud] | Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry. |
| 001688 (2017) |
A. Strangfeld [Allemagne] ; A. Richter [Allemagne] ; B. Siegmund [Allemagne] ; P. Herzer [Allemagne] ; K. Rockwitz [Allemagne] ; W. Demary [Allemagne] ; M. Aringer [Allemagne] ; Y. Mei Ner [Allemagne] ; A. Zink [Allemagne] ; J. Listing [Allemagne] | Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. |
| 001689 (2017) |
Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis ; René Marc Flipo ; Stéphanie Rist ; Bernard Combe [France] ; Jacques Eric Gottenberg [France] ; Thierry Schaeverbeke ; Martin Soubrier ; Olivier Vittecoq ; Maxime Dougados [France] ; Alain Saraux ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France] | Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE. |
| 001723 (2017) |
Yukiko Kimura [États-Unis] ; Sriharsha Grevich [États-Unis] ; Timothy Beukelman [États-Unis] ; Esi Morgan [États-Unis] ; Peter A. Nigrovic [États-Unis] ; Kelly Mieszkalski [États-Unis] ; T Brent Graham [États-Unis] ; Maria Ibarra [États-Unis] ; Norman Ilowite [États-Unis] ; Marisa Klein-Gitelman [États-Unis] ; Karen Onel [États-Unis] ; Sampath Prahalad [États-Unis] ; Marilynn Punaro [États-Unis] ; Sarah Ringold [États-Unis] ; Dana Toib [États-Unis] ; Heather Van Mater [États-Unis] ; Jennifer E. Weiss [États-Unis] ; Pamela F. Weiss [États-Unis] ; Laura E. Schanberg [États-Unis] | Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans. |
| 001753 (2017) |
Hjalmar Wadström [Suède] ; Thomas Frisell [Suède] ; Johan Askling [Suède] | Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice |
| 001805 (2017) |
Daniel Glinatsi [Danemark] ; Marte S. Heiberg [Norvège] ; Anna Rudin [Suède] ; Dan Nordström [Finlande] ; Espen A. Haavardsholm [Norvège] ; Bjorn Gudbjornsson [Islande] ; Mikkel Stergaard [Danemark] ; Till Uhlig [Norvège] ; Gerdur Grondal [Islande] ; Kim H Rslev-Petersen [Danemark] ; Ronald Van Vollenhoven [Suède] ; Merete L. Hetland [Danemark] | Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study. |
| 001815 (2017) |
Sara Monti [Italie] ; Catherine Klersy [Italie] ; Roberto Gorla [Italie] ; Piercarlo Sarzi-Puttini [Italie] ; Fabiola Atzeni [Italie] ; Raffaele Pellerito [Italie] ; Enrico Fusaro [Italie] ; Giuseppe Paolazzi [Italie] ; Pier Andrea Rocchetta [Italie] ; Ennio Giulio Favalli [Italie] ; Antonio Marchesoni [Italie] ; Roberto Caporali [Italie] | Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. |
| 001816 (2017) |
Gerd Horneff [Allemagne] ; Anna Carina Schulz [Allemagne] ; Jens Klotsche [Allemagne] ; Anton Hospach [Allemagne] ; Kirsten Minden [Allemagne] ; Ivan Foeldvari [Allemagne] ; Ralf Trauzeddel [Allemagne] ; Gerd Ganser [Allemagne] ; Frank Weller-Heinemann [Allemagne] ; Johannes Perter Haas [Allemagne] | Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry. |
| 001838 (2017) |
Tanja Schj Dt J Rgensen [Danemark] ; Carl Turesson [Suède] ; Meliha Kapetanovic [Suède] ; Martin Englund [Suède] ; Aleksandra Turkiewicz [Suède] ; Robin Christensen [Danemark] ; Henning Bliddal [Danemark] ; Pierre Geborek [Suède] ; Lars Erik Kristensen [Danemark] | EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry. |
| 001891 (2017) |
Francisco Espinoza [Chili] ; Pierre Le Blay [Chili] ; Bernard Combe [Chili] | Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD. |
| 001901 (2017) |
Jessica M. Franklin [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; Daniel H. Solomon [États-Unis] | Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases. |
| 001987 (2016) |
Shumpei Yokota [Japon] ; Yasuhiko Itoh [Japon] ; Tomohiro Morio [Japon] ; Hideki Origasa [Japon] ; Naokata Sumitomo [Japon] ; Minako Tomobe [Japon] ; Kunihiko Tanaka [Japon] ; Seiji Minota [Japon] | Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan. |
| 001A44 (2016) |
Patrick Verschueren [Belgique] | Should rheumatoid arthritis patients preferentially be treated with tocilizumab after rituximab failure? |
| 001A56 (2016) |
Ulrich A. Walker [Suisse] ; Veronika K. Jaeger [Suisse] ; Katerina Chatzidionysiou [Suède] ; Merete L. Hetland ; Ellen-Margrethe Hauge [Danemark] ; Karel Pavelka [République tchèque] ; Dan C. Nordström [Finlande] ; Helena Canhão ; Matija Tomši ; Ronald Van Vollenhoven [Suède] ; Cem Gabay [Suisse] | Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis. |
| 001A57 (2016) |
Louise K. Mercer [Royaume-Uni] ; Johan Askling [Suède] ; Pauline Raaschou [Suède] ; William G. Dixon [Royaume-Uni] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark] ; Anja Strangfeld [Allemagne] ; Angela Zink [Allemagne] ; Xavier Mariette [France] ; Axel Finckh [Suisse] ; Helena Canhao [Portugal] ; Florenzo Iannone [Italie] ; Jakub Zavada [République tchèque] ; Jacques Morel [France] ; Jacques-Eric Gottenberg [France] ; Kimme L. Hyrich [Royaume-Uni] ; Joachim Listing [Allemagne] | Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers |
| 001A75 (2016) |
Alejandro Souto [Oman] ; José Ram N Maneiro ; Juan J. G Mez-Reino [Espagne] | Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases. |
| 001B46 (2016) |
Toshihisa Kojima [Japon] ; Nobunori Takahashi ; Koji Funahashi ; Shuji Asai ; Kenya Terabe ; Atsushi Kaneko [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Takeshi Oguchi [Japon] ; Hideki Takagi [Japon] ; Yasuhide Kanayama [Japon] ; Yuichiro Yabe [Japon] ; Tsuyoshi Watanabe [Japon] ; Takayoshi Fujibayashi [Japon] ; Tomone Shioura [Japon] ; Takayasu Ito [Japon] ; Yutaka Yoshioka [Japon] ; Hisato Ishikawa [Japon] ; Nobuyuki Asai ; Toki Takemoto ; Masayo Kojima [Japon] ; Naoki Ishiguro | Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study. |
